PanCAN CEO Julie Fleshman Calls for Federal Funding at World Pancreatic Cancer Day Roundtable
Pancreatic Cancer Action Network President and CEO Julie Fleshman called for sustained federal investment in pancreatic cancer research during a World Pancreatic Cancer Day roundtable with Rep. Terri Sewell and members of Congress, Oncodaily reported.
Fleshman said the meeting in Washington, D.C., focused on advancements in early detection and treatment and the opportunities ahead with continued funding. “It is critical that policymakers understand both how far we have come and the opportunities ahead to accelerate progress for the pancreatic cancer community,” she said.
The roundtable was part of a week of events culminating in World Pancreatic Cancer Day. In Northern California, Fleshman hosted “All Together, We Can: An Evening for Science and Survival” to recognize research advances. Event co-chairs included Linda Amuso, Linda and John Knoll, Hilarie Koplow-McAdams and Steve McAdams, and Nicole and Amir Dan Rubin.
PanCAN Chief Scientific and Medical Officer Anna Berkenblit thanked PanCAN Scientific and Medical Advisory Board member Brian Wolpin for joining Fleshman at the congressional meeting. “Special thanks to Brian Wolpin, PanCAN Scientific and Medical Advisory Board member, for joining PanCAN CEO Julie Fleshman at Congresswoman Terri Sewell’s pancreatic cancer meeting yesterday to raise awareness of the need for continued research funding!”
Berkenblit said.
Landmarks across the United States illuminated purple for the day, while World Pancreatic Cancer Coalition member organizations coordinated illuminations globally. PanCAN volunteers hosted events and shared stories to raise awareness. “All together, we can change the story of pancreatic cancer,” Fleshman said. “The progress is real, the opportunities are significant and our work is far from finished.”